R167K (p.Arg167Lys) variant of SLC40A1 (Ferroportin)

R167K (p.Arg167Lys) in SLC40A1 (Ferroportin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.50 / 1. The record also includes population frequency data and structural context.

R167K (p.Arg167Lys) variant details